Beit Jala Pharmaceutical Company reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was JOD 2.25 million compared to JOD 2.47 million a year ago. Sales was JOD 2.25 million compared to JOD 2.47 million a year ago.

Net income was JOD 0.427101 million compared to JOD 0.397198 million a year ago. Net income was JOD 0.427101 million compared to JOD 0.397198 million a year ago. Basic earnings per share from continuing operations was JOD 0.061 compared to JOD 0.057 a year ago.

Basic earnings per share from continuing operations was JOD 0.061 compared to JOD 0.057 a year ago.